研究發表與專利 

Publications

 

專利 Patents

1. Monoclonal antibody with the capability of neutralizing enterovirus type 71. (2010) US7718775.

2. 球松素用於製備降低LDL膽固醇之組合物之用途 (2019) 中華民國【發明專利I674895號】


研討會 Posters (International Conference) :     

1.    Lin YX, Yen JH, Wu CL, Lin LI, Chen PY (2023, Sep). Targeting Cytarabine-Resistant Polyploid Giant Cancer Cells (PGCCs) in AML with Shikonin. Pan Pacific Symposium on stem cells and cancer research 2023, Hualien, Taiwan.

2.    Chen PY, Keak PY, Wu CL, Yen JH (2023, Jun). The Anti-Leukemic Activity of Shikonin in Core Binding Factor (CBF) AML: in vitro and in vivo biological studies. European Human Genetics Conference 2023, Glasgow, UK.

3.    Yen JH, Su YC, Lee YS, Chien CC, Weng CY, Chu SY, Chen PY (2022, Jun). A maternal inherited rare case with chromoanagenesis-related complex chromosomal rearrangements and de novo microdeletions. European Human Genetics Conference 2022, Vienna, Austria.

4.    Yen JH, Chen ZA, Lin LI, Chen PY (2020, Jun). Molecular studies for gain of cytarabine-resistance in AML cells with FLT3-ITD mutations. European Human Genetics Virtual Conference 2020, Vienna, Austria.

5.    Chen PY, Chen HJ, Yen JH (2019, Sep). Shikonin exhibits anti-proliferative effects and down-regulates RUNX1-ETO expression in AML Kasumi-1 cells. The 78th Annual Meeting of the Japanese Cancer Association, Kyoto, Japan.

6.    Yen JH, Chen ZA, Lin LI, Chen PY (2019, Jun). Characterization of genomic alterations of cytarabine-resistant AML cells with FLT3-ITD mutation. European Human Genetics Conference 2019, Gothenburg, Sweden.

7.    Chung CH, Gao WY, Chen PY, Yen JH (2018, Sep). Nobiletin and 5-demethylnobiletin promote cell differentiation and exert anti-leukemic effects on human CML cells. The 77th Annual Meeting of the Japanese Cancer Association, Osaka, Japan.

8.    Thang SK, Chen PY, Yen JH (2017, Nov). Xanthohumol Modulates Intestival Cholesterol Absorption via down-regulation of Niemann-Pick C1 like 1 (NPC1L1) Gene Expression. ACS The 1st Asia-Pacific International Conference. Busan, South Korea.

9.    Chen PY, Chen YT, Kao RH, Wu MJ, Tai MH, Ho CT, Yen JH (2016, Oct). Nobiletin and 5-demethylnobiletin suppress c-KIT expression via ERK pathway and inhibit cell proliferation in AML cells. The 75th Annual Meeting of the Japanese Cancer Association. Yokohama, Japan.

10.  Chen YT, Tai1 MH, Wu MJ, Ho CT, Yen JH, Chen PY (2015, Oct). Citrus polymethoxyflavone nobiletin down-regulates c-KIT expression in human leukemia cells. The 74th Annual Meeting of the Japanese Cancer Association. Nagoya, Japan.

11.  Chen HC, Wu MJ, Chen PY, Chen YC, Tai MH, Yen JH (2015, Aug). Tanshinone IIA modulates cell-surface LDLR level and LDL uptake via suppression of PCSK9 gene expression in HepG2 cells. 250th American Chemical Society National Meeting & Exposition, Boston, USA.

12.  Tien HJ, Chen PY, Chen JH, Wu MJ, Yen JH (2015, Aug). Luteolin-mediated apoptosis in leukemia cells involves PTTG1 oncoprotein and differential responses. 250th American Chemical Society National Meeting & Exposition, Boston, USA.

13.  Chen PY, Chen PK, Tai MH, Chen JH, en JH(2014, Oct). Nobiletin suppresses oncogene PTTG1 expression in THP1 leukemia cells. The 73rd Annual Meeting of the Japanese Cancer Association. Yokohama, Japan.

14.  Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH (2013, Apr). Curcumin decreases PCSK9 gene expression via regulation of hepatocyte nuclear factor 1α (HNF1α) in HepG2 cells. Pharma-Nutrition, 2013, Apr.15-17. Singapore.